Dentsply Sirona Stock News

DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Baird 2025 Global Healthcare Conference September 9, 2025 1:25 PM EDT Company Participants Matthew Garth - Executive VP & CFO Conference Call Participants Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Presentation Jeffrey Johnson Senior Research Analyst All right.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 2:35 PM EDT Company Participants Daniel Scavilla - President, CEO & Director Matthew Garth - Executive VP & CFO Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Presentation Erin Wilson Wright Equity Analyst Good afternoon, everyone. My name is Erin Wr...

Determined that Wellspect will Deliver Greater Financial and Strategic Benefits to Stockholders as Part of the Company Determined that Wellspect will Deliver Greater Financial and Strategic Benefits to Stockholders as Part of the Company

CHARLOTTE, N.C., Aug. 26, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.

XRAY's EDS and Wellspect are the key to stabilizing their results going forward. OIS and CTS continue to decline, but SureSmile grows in Europe. Their new CEO will also prioritize execution, rather than reinventing XRAY. They'll double down on integrated digital workflows and better customer experience. If they build a stickier ecosystem, I think XRAY does have the potential for a turnaround.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Q2 2025 Earnings Call August 7, 2025 8:30 AM ET Company Participants Andrea Daley - Vice President of Investor Relations Daniel T. Scavilla - President, CEO & Director Matthew E.

Dentsply Sirona (XRAY) Q2 Sales Drop 5%

CHARLOTTE, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the second quarter of 2025.